← Eichor
Study identifier: NCT07564531 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of a Combined Dexmedetomidine-Ketamine Sedation Regimen for Pediatric Cardiac Catheterization

Condition: Cardiac Catheterization · Pediatric  ·  Sponsor: National Children's Hospital, Vietnam

PhaseN/A
Planned participants150
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

The goal of this observational study is to learn if the spontaneous sedation regimen of dexmedetomidine-ketamine (KETADEX) has the comparable efficacy and safety in pediatric cardiac catheterization versus the traditional regimen. The main question it aims to answer is: Is the combined Dexmedetomidine-Ketamine spontaneous sedation regimen (KETADEX) non-inferior to the traditional general anesthesia regimen in terms of efficacy and safety? Participants would received either KETADEX regimen or general anesthesia regimen. Research members then observe the catheterization procedure and answer the questionnaire about their efficacy and safety.

This description comes directly from the study's public registry record.

Talk to the study team

Hong Ha Thi Nguyen, PhD  ·  +84904111838  ·  honghant@nch.gov.vn

Nhat Minh Tran, BPharm, MSc  ·  +84936110303  ·  nhatminh@nch.gov.vn

Always discuss trial participation with your own doctor first.

Locations (1)

Vietnam National Children's HospitalHanoi, VietnamRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07564531